Skip to main content

Advertisement

Table 2 Procedural characteristics

From: Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center

  2009 ( n= 2,098) 2010 ( n= 2,790) P value
Total N Mean or n SD or percentage Total N Mean or n SD or percentage
Emergency surgery (n,%) 1,878 149 7.9 2,677 226 8.4 0.5390
ASA class (n,%) 1,880    2,682    0.0045
 1   48 2.6   59 2.2 0.4376
 2   636 33.8   785 29.3 0.0011
 3   1,074 57.1   1,612 60.1 0.0443
 4   120 6.4   222 8.3 0.0168
 5   2 0.1   4 0.1 1.0000
Procedure category 1,977    2,774    <0.0001
 Misc. diagnostic (n,%)   4 0.2   10 0.4 0.4202
 Obstetrical (n,%)   21 1.1   37 1.3 0.4007
 Cardiovascular (n,%)   153 7.7   301 10.9 0.0003
 Digestive (n,%)   398 20.1   530 19.1 0.3795
 Ear (n,%)   32 1.6   73 2.6 0.0192
 Endocrine (n,%)   17 0.9   33 1.2 0.2723
 Eye (n,%)   3 0.2   4 0.1 1.0000
 Female genital (n,%)   104 5.3   127 4.6 0.2811
 Heme/lymphatic (n,%)   35 1.8   47 1.7 0.8427
 Integumentary (n,%)   62 3.1   102 3.7 0.3141
 Male genital (n,%)   104 5.3   104 3.7 0.0121
 Musculoskeletal (n,%)   689 34.9   857 30.9 0.0041
 Nervous system (n,%)   30 1.5   114 4.1 <0.0001
 Nose, mouth, pharynx (n,%)   0 0   9 0.3 0.0129
 Thoracic (n,%)   123 6.2   137 4.9 0.0553
 Urinary (n,%)   139 7   199 7.2 0.8502
 Other (n,%)   63 3.2   90 3.2 0.9115
General anes used (n,%) 1,977 1,848 93.5 2,774 2,499 90.1 <0.0001
Regional anes used (n,%) 1,977 647 32.7 2,774 930 33.5 0.5642
Surg. time (mins) (mean, SD) 1,505 240.8 128.6 2,399 242 131.8 0.8516
Rec’d any RBC, FFP, cryo (n,%) 1,977 440 22.3 2,774 578 20.8 0.2398
Days of follow-up (mean, SD) 1,976 1,081.6 323.6 2,774 776.7 211.6 <0.0001
  1. Anes, anesthesia; SD, standard deviation; Misc, miscellaneous; Rec’d, received; RBC, red blood cell; Surg., surgical; Mins, minutes; FFP, fresh frozen plasma; Cryo, cryoprecipitate.